This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2016 Apr;16(2):139.

doi: 10.1007/s40256-016-0167-2.

Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial

Il Suk Sohn¹, Chong-Jin Kim¹, Byung-Hee Oh², Taek-Jong Hong³, Chang-Gyu Park⁴, Byung-Soo Kim⁵, Woo-Baek Chung⁶; Investigators

Affiliations

Affiliations

¹ Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.
² Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-ro(28 Yongondong), Jongno-gu, Seoul, 110-744, Republic of Korea. ohbhmed@snu.ac.kr.
³ Pusan National University Hospital, Busan, Republic of Korea.
⁴ Korea University Guro Hospital, Seoul, Republic of Korea.
⁵ Daedong Hospital, Busan, Republic of Korea.
⁶ Yeouido St. Mary's Hospital of the Catholic University of Korea, Seoul, Republic of Korea.

PMID: 26994003
PMCID: PMC4969791
DOI: 10.1007/s40256-016-0167-2

Published Erratum

Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial

Il Suk Sohn et al. Am J Cardiovasc Drugs. 2016 Apr.

. 2016 Apr;16(2):139.

doi: 10.1007/s40256-016-0167-2.

Authors

Il Suk Sohn¹, Chong-Jin Kim¹, Byung-Hee Oh², Taek-Jong Hong³, Chang-Gyu Park⁴, Byung-Soo Kim⁵, Woo-Baek Chung⁶; Investigators

Affiliations

¹ Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.
² Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-ro(28 Yongondong), Jongno-gu, Seoul, 110-744, Republic of Korea. ohbhmed@snu.ac.kr.
³ Pusan National University Hospital, Busan, Republic of Korea.
⁴ Korea University Guro Hospital, Seoul, Republic of Korea.
⁵ Daedong Hospital, Busan, Republic of Korea.
⁶ Yeouido St. Mary's Hospital of the Catholic University of Korea, Seoul, Republic of Korea.

PMID: 26994003
PMCID: PMC4969791
DOI: 10.1007/s40256-016-0167-2

No abstract available

PubMed Disclaimer

Erratum for

Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
Sohn IS, Kim CJ, Oh BH, Hong TJ, Park CG, Kim BS, Chung WB; Investigators. Sohn IS, et al. Am J Cardiovasc Drugs. 2016 Apr;16(2):129-38. doi: 10.1007/s40256-015-0156-x. Am J Cardiovasc Drugs. 2016. PMID: 26691333 Free PMC article. Clinical Trial.

Similar articles

Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
Chrysant SG, Chavanu KJ, Xu J. Chrysant SG, et al. Am J Cardiovasc Drugs. 2009;9(4):241-51. doi: 10.2165/00129784-200909040-00001. Am J Cardiovasc Drugs. 2009. PMID: 19655819 Clinical Trial.
Effect of an olmesartan medoxomil-based treatment algorithm on systolic blood pressure in patients with stage 1 or 2 hypertension: a randomized, double-blind, placebo-controlled study.
Kereiakes DJ, Maa JF, Shojaee A, Dubiel R. Kereiakes DJ, et al. Am J Cardiovasc Drugs. 2010;10(4):239-46. doi: 10.2165/11538630-000000000-00000. Am J Cardiovasc Drugs. 2010. PMID: 20653330 Clinical Trial.
Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide.
Chrysant SG, Weber MA, Wang AC, Hinman DJ. Chrysant SG, et al. Am J Hypertens. 2004 Mar;17(3):252-9. doi: 10.1016/j.amjhyper.2003.11.003. Am J Hypertens. 2004. PMID: 15001200 Clinical Trial.
Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension.
Ram CV. Ram CV. Expert Rev Cardiovasc Ther. 2011 Jan;9(1):9-19. doi: 10.1586/erc.10.163. Expert Rev Cardiovasc Ther. 2011. PMID: 21166525 Review.
Antihypertensive efficacy of olmesartan compared with other antihypertensive drugs.
Stumpe KO, Ludwig M. Stumpe KO, et al. J Hum Hypertens. 2002 May;16 Suppl 2:S24-8. doi: 10.1038/sj.jhh.1001395. J Hum Hypertens. 2002. PMID: 11967729 Review.

See all similar articles

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations